Kathryn Rost1, Jeffrey L Smith, Miriam Dickinson. 1. Department of Family Medicine, University of Colorado Health Sciences Center, Aurora, Colorado, USA. Kathryn.Rost@uchsc.edu
Abstract
OBJECTIVE: To test whether an intervention to improve primary care depression management significantly improves productivity at work and absenteeism over 2 years. SETTING AND SUBJECTS:Twelve community primary care practices recruiting depressed primary care patients identified in a previsit screening. RESEARCH DESIGN: Practices were stratified by depression treatment patterns before randomization to enhanced or usual care. After delivering brief training, enhanced care clinicians provided improved depression management over 24 months. The research team evaluated productivity and absenteeism at baseline, 6, 12, 18, and 24 months in 326 patients who reported full-or part-time work at one or more completed waves. RESULTS: Employed patients in the enhanced care condition reported 6.1% greater productivity and 22.8% less absenteeism over 2 years. Consistent with its impact on depression severity and emotional role functioning, intervention effects were more observable in consistently employed subjects where the intervention improved productivity by 8.2% over 2 years at an estimated annual value of US 1982 dollars per depressed full-time equivalent and reduced absenteeism by 28.4% or 12.3 days over 2 years at an estimated annual value of US 619 dollars per depressed full-time equivalent. CONCLUSIONS: This trial, which is the first to our knowledge to demonstrate that improving the quality of care for any chronic disease has positive consequences for productivity and absenteeism, encourages formal cost-benefit research to assess the potential return-on-investment employers of stable workforces can realize from using their purchasing power to encourage better depression treatment for their employees.
RCT Entities:
OBJECTIVE: To test whether an intervention to improve primary care depression management significantly improves productivity at work and absenteeism over 2 years. SETTING AND SUBJECTS: Twelve community primary care practices recruiting depressed primary care patients identified in a previsit screening. RESEARCH DESIGN: Practices were stratified by depression treatment patterns before randomization to enhanced or usual care. After delivering brief training, enhanced care clinicians provided improved depression management over 24 months. The research team evaluated productivity and absenteeism at baseline, 6, 12, 18, and 24 months in 326 patients who reported full-or part-time work at one or more completed waves. RESULTS: Employed patients in the enhanced care condition reported 6.1% greater productivity and 22.8% less absenteeism over 2 years. Consistent with its impact on depression severity and emotional role functioning, intervention effects were more observable in consistently employed subjects where the intervention improved productivity by 8.2% over 2 years at an estimated annual value of US 1982 dollars per depressed full-time equivalent and reduced absenteeism by 28.4% or 12.3 days over 2 years at an estimated annual value of US 619 dollars per depressed full-time equivalent. CONCLUSIONS: This trial, which is the first to our knowledge to demonstrate that improving the quality of care for any chronic disease has positive consequences for productivity and absenteeism, encourages formal cost-benefit research to assess the potential return-on-investment employers of stable workforces can realize from using their purchasing power to encourage better depression treatment for their employees.
Authors: Debra Lerner; Benjamin C Amick; Jennifer C Lee; Ted Rooney; William H Rogers; Hong Chang; Ernst R Berndt Journal: Med Care Date: 2003-05 Impact factor: 2.983
Authors: Paul A Nutting; Kathryn Rost; Miriam Dickinson; James J Werner; Perry Dickinson; Jeffrey L Smith; Beth Gallovic Journal: J Gen Intern Med Date: 2002-02 Impact factor: 5.128
Authors: K Kroenke; S L West; R Swindle; A Gilsenan; G J Eckert; R Dolor; P Stang; X H Zhou; R Hays; M Weinberger Journal: JAMA Date: 2001-12-19 Impact factor: 56.272
Authors: C D Sherbourne; K B Wells; N Duan; J Miranda; J Unützer; L Jaycox; M Schoenbaum; L S Meredith; L V Rubenstein Journal: Arch Gen Psychiatry Date: 2001-07
Authors: Lauren A Smith; Diana Romero; Pamela R Wood; Nina S Wampler; Wendy Chavkin; Paul H Wise Journal: Am J Public Health Date: 2002-09 Impact factor: 9.308
Authors: Andrea D Furlan; William H Gnam; Nancy Carnide; Emma Irvin; Benjamin C Amick; Kelly DeRango; Robert McMaster; Kimberley Cullen; Tesha Slack; Sandra Brouwer; Ute Bültmann Journal: J Occup Rehabil Date: 2012-09
Authors: Daphna Levinson; Matthew D Lakoma; Maria Petukhova; Michael Schoenbaum; Alan M Zaslavsky; Matthias Angermeyer; Guilherme Borges; Ronny Bruffaerts; Giovanni de Girolamo; Ron de Graaf; Oye Gureje; Josep Maria Haro; Chiyi Hu; Aimee N Karam; Norito Kawakami; Sing Lee; Jean-Pierre Lepine; Mark Oakley Browne; Michail Okoliyski; José Posada-Villa; Rajesh Sagar; Maria Carmen Viana; David R Williams; Ronald C Kessler Journal: Br J Psychiatry Date: 2010-08 Impact factor: 9.319
Authors: Debra Lerner; David A Adler; William H Rogers; Hong Chang; Annabel Greenhill; Elina Cymerman; Francisca Azocar Journal: Psychiatr Serv Date: 2015-03-01 Impact factor: 3.084
Authors: Ronald C Kessler; Hagop S Akiskal; Minnie Ames; Howard Birnbaum; Paul Greenberg; Robert M A Hirschfeld; Robert Jin; Kathleen R Merikangas; Gregory E Simon; Philip S Wang Journal: Am J Psychiatry Date: 2006-09 Impact factor: 18.112
Authors: Amy M Kilbourne; Herbert C Schulberg; Edward P Post; Bruce L Rollman; Bea Herbeck Belnap; Harold Alan Pincus Journal: Milbank Q Date: 2004 Impact factor: 4.911
Authors: Kathleen R Merikangas; Minnie Ames; Lihong Cui; Paul E Stang; T Bedirhan Ustun; Michael Von Korff; Ronald C Kessler Journal: Arch Gen Psychiatry Date: 2007-10